Pancreas Disorder and Islet Transplantation

Stem cell-derived pancreatic islet transplantation is a β-cell replacement therapy which involves transplantation of isolated islets from donor pancreas to receiver, for the treatment of insulin-deficient diabetes. Once they are transplanted, the islets start producing insulin and actively regulate blood glucose levels. It was observed that 70% of patients who received an islet cell transplant no longer needs insulin after one year and may not need it in the future. Some of the benefits of Islet Transplantation are

  • Improved blood glucose levels
  • Less need or no need for insulin injections to manage diabetes
  • Fewer or no episodes of severe hypoglycaemia

Related Conference of Pancreas Disorder and Islet Transplantation

February 24-25, 2025

34th European Diabetes Congress

London, UK
March 10-11, 2025

4th Global Summit on Physiology and Metabolism of Thyroid

Singapore City, Singapore
March 17-18, 2025

5th European Endocrinology and Diabetes Congress

Paris, France
April 10-11, 2025

5th World Congress on Endocrine and Diabetes

Dubai, UAE
April 10-11, 2025

4th International Summit on Hormonal Disorders

Dubai, UAE
May 19-20, 2025

6th World Summit on Diabetes

Rome, Italy
June 04-05, 2025

4th World Congress on Diabetes and Pediatric Endocrinology

Edinburgh, Scotland
July 29-30, 2025

15th World Congress on Endocrinology and Diabetes

Aix-en-Provence, France
September 08-09, 2025

3rd World congress and Expo on Diabetes

Frankfurt, Germany
November 06-07, 2025

8th Annual Meeting on Diabetes and Endocrinology

Dubai, UAE
November 20-21, 2025

21st World Congress on Endocrinology & Diabetes

Aix-en-Provence, France

Pancreas Disorder and Islet Transplantation Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in